speb/financial-data huggingface dataset:
CLLS cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -152000.00
CLLS cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 648000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 166972000.00
CLLS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 4223000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2015000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2015000.00
CLLS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 19011000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 33138000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 45729000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 78867000.00
CLLS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3939000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 5196000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 750000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -18128000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -18128000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -18128000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
CLLS income_statement (quarterly, 2025-03-31) — Net Interest Income: 1001000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 4617000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -3939000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -3939000.00
CLLS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1001000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 1000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Net PPE: 72933000.00
CLLS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -395000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 115962000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 13443000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1139000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 927000.00
CLLS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -6336000.00
CLLS income_statement (quarterly, 2025-03-31) — Normalized Income: -13179000.00
CLLS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -17160000.00
CLLS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 751000.00
CLLS income_statement (quarterly, 2025-03-31) — Operating Income: -14179000.00
CLLS income_statement (quarterly, 2025-03-31) — Operating Revenue: 10297000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 100290220.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 295000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 5039000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 12908000.00
CLLS income_statement (quarterly, 2025-03-31) — Other Gand A: 242000.00
CLLS income_statement (quarterly, 2025-03-31) — Other Income Expense: -4949000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 242000.00
CLLS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4873000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2320000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 852000.00
CLLS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -1799000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Properties: 93915000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 114055000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Payables: 17250000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 22610000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 28000000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2317000.00
CLLS income_statement (quarterly, 2025-03-31) — Pretax Income: -18127000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 8000.00
CLLS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
CLLS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -5037000.00
CLLS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -395000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Receivables: 25521000.00
CLLS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2015000.00
CLLS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 4931000.00
CLLS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3939000.00
CLLS income_statement (quarterly, 2025-03-31) — Research And Development: 21932000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 2000000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -347691000.00
CLLS income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2091000.00
CLLS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 9654000.00
CLLS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2333000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Share Issued: 100290220.00
CLLS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 976000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 116204000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 115962000.00
CLLS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLLS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CLLS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 17651000.00
CLLS cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 0.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Assets: 364086000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 161933000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Debt: 91768000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 116204000.00
CLLS income_statement (quarterly, 2025-03-31) — Total Expenses: 24834000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 247882000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 92262000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 85316000.00
CLLS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -14179000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 41000.00
CLLS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -4949000.00
CLLS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4949000.00
CLLS balance_sheet (quarterly, 2025-03-31) — Working Capital: 109258000.00
CLLS income_statement (quarterly, 2025-06-30) — +Operating Expense: 23887000.00
CLLS income_statement (quarterly, 2025-06-30) — +Total Revenue: 16725000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 17522000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8776000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -106055000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 433549000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 1934000.00
CLLS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 127636000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 53692000.00
CLLS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -305000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 39741000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5902000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 59809000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 196150000.00
CLLS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
CLLS balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 17973000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 41837000.00
CLLS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4270000.00
CLLS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -52717000.00
CLLS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -10310000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 23000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -8901000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Payable: 23000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 23000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3388000.00
CLLS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -12266000.00
CLLS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -1883000.00
CLLS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -67298000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Common Stock: 5902000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 97111000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 667000.00
CLLS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2425000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 7374000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Assets: 230641000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 7477000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Debt: 5469000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 12946000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 113379000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 113379000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 167432000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Current Provisions: 875000.00
CLLS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
CLLS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
CLLS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5017000.00
CLLS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 365000.00
CLLS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5017000.00
CLLS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 365000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 5484000.00
CLLS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — EBIT: -21681000.00
CLLS income_statement (quarterly, 2025-06-30) — EBITDA: -16664000.00
CLLS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -529000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1303000.00
CLLS cash_flow (quarterly, 2025-06-30) — End Cash Position: 59809000.00
CLLS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4271000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: -33885000.00
CLLS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -10615000.00
CLLS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -14289000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -33885000.00
CLLS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2289000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1153000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 8776000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 176228000.00
CLLS income_statement (quarterly, 2025-06-30) — Gross Profit: 14300000.00
CLLS income_statement (quarterly, 2025-06-30) — Interest Expense: 2055000.00
CLLS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2055000.00
CLLS income_statement (quarterly, 2025-06-30) — Interest Income: 2195000.00
CLLS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2195000.00
CLLS cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -192000.00
CLLS cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 8262000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 152143000.00
CLLS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -52717000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1934000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1934000.00
CLLS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CLLS balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 20664000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 32264000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 49563000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 81827000.00
CLLS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CLLS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4078000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 5419000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 287000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -23735000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -23735000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -23735000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
CLLS income_statement (quarterly, 2025-06-30) — Net Interest Income: 140000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -52412000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -4078000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -4078000.00
CLLS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 140000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
CLLS balance_sheet (quarterly, 2025-06-30) — Net PPE: 70173000.00
CLLS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -305000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 95958000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 16127000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1303000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 31237000.00
CLLS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2375000.00
CLLS income_statement (quarterly, 2025-06-30) — Normalized Income: -9446000.00
CLLS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -10310000.00
CLLS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 287000.00
CLLS income_statement (quarterly, 2025-06-30) — Operating Income: -9587000.00
CLLS income_statement (quarterly, 2025-06-30) — Operating Revenue: 16214000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 100325229.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 298000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 5469000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 15293000.00
CLLS income_statement (quarterly, 2025-06-30) — Other Gand A: 227000.00
CLLS income_statement (quarterly, 2025-06-30) — Other Income Expense: -14289000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1153000.00
CLLS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 10852000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2320000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 809000.00
CLLS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -1847000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Properties: 95786000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 136341000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Payables: 17565000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 24939000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2823000.00
CLLS income_statement (quarterly, 2025-06-30) — Pretax Income: -23736000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CLLS cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -9000.00
CLLS cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: 0.00
CLLS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -144139000.00
CLLS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -305000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Receivables: 29370000.00
CLLS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2425000.00
CLLS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5017000.00
CLLS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4078000.00
CLLS income_statement (quarterly, 2025-06-30) — Research And Development: 23080000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 2000000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -308455000.00
CLLS income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2062000.00
CLLS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 91727000.00
CLLS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2289000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Share Issued: 100325229.00
CLLS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1282000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 97111000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 95958000.00
CLLS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLLS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
CLLS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CLLS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 20594000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Assets: 353966000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 146674000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Debt: 94773000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 97111000.00
CLLS income_statement (quarterly, 2025-06-30) — Total Expenses: 26312000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 256855000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 123326000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 89423000.00
CLLS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -9587000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 43000.00
CLLS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -14289000.00
CLLS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -14289000.00
CLLS balance_sheet (quarterly, 2025-06-30) — Working Capital: 63209000.00
CLLS income_statement (quarterly, 2025-09-30) — +Operating Expense: 24774000.00
CLLS income_statement (quarterly, 2025-09-30) — +Total Revenue: 35172000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 16095000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8056000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -110854000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 435162000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1853000.00
CLLS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 100325229.00
CLLS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
CLLS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 59809000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 53736000.00
CLLS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2343000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 37583000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5902000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 52243000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 190223000.00
CLLS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 2794000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 49449000.00
CLLS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4259000.00
CLLS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3440000.00
CLLS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1573000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 510000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -18920000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Payable: 510000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 510000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1674000.00
CLLS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -16736000.00
CLLS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 3666000.00
CLLS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -9271000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Common Stock: 5902000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 100478000.00
CLLS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1736000.00
CLLS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2357000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 8888000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Assets: 221193000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 8331000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Debt: 5454000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 13785000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 94008000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 94008000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 148577000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 1082000.00
CLLS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
CLLS cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
CLLS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5011000.00
CLLS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 372000.00
CLLS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5011000.00
CLLS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 372000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 12887000.00
CLLS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 101708538.00
CLLS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.01
CLLS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 589000.00
CLLS income_statement (quarterly, 2025-09-30) — EBIT: 2696000.00
CLLS income_statement (quarterly, 2025-09-30) — EBITDA: 7707000.00
CLLS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 1705000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1339000.00
CLLS cash_flow (quarterly, 2025-09-30) — End Cash Position: 52243000.00
CLLS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4260000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -32725000.00
CLLS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3914000.00
CLLS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -7658000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -32725000.00
CLLS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2479000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 845000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 8056000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 177564000.00
CLLS income_statement (quarterly, 2025-09-30) — Gross Profit: 32815000.00
CLLS income_statement (quarterly, 2025-09-30) — Interest Expense: 2107000.00
CLLS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2107000.00
CLLS income_statement (quarterly, 2025-09-30) — Interest Income: 2313000.00
CLLS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2313000.00
CLLS cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -157000.00
CLLS cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: -1799000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 155671000.00
CLLS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3441000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1853000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1853000.00
CLLS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLLS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 20703000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 29252000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 49739000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 78991000.00
CLLS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CLLS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -4102000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 5435000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2950000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 21137000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income: 589000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 589000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 589000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 589000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 589000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 588000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 589000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -1162000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Interest Income: 206000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1097000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -4102000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -4102000.00
CLLS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 206000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Net PPE: 66710000.00
CLLS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1181000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 99633000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 18179000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 382000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 1339000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 31562000.00
CLLS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 15365000.00
CLLS income_statement (quarterly, 2025-09-30) — Normalized Income: 8247000.00
CLLS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1571000.00
CLLS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 19193000.00
CLLS income_statement (quarterly, 2025-09-30) — Operating Income: 8041000.00
CLLS income_statement (quarterly, 2025-09-30) — Operating Revenue: 35172000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 100325229.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 316000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 5454000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 14657000.00
CLLS income_statement (quarterly, 2025-09-30) — Other Gand A: 216000.00
CLLS income_statement (quarterly, 2025-09-30) — Other Income Expense: -7658000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 845000.00
CLLS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -9652000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2321000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 773000.00
CLLS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -2146000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Properties: 95954000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 137980000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Payables: 16157000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 25045000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2239000.00
CLLS income_statement (quarterly, 2025-09-30) — Pretax Income: 589000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CLLS cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 222000.00
CLLS cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -1162000.00
CLLS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3412000.00
CLLS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1181000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Receivables: 26415000.00
CLLS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2357000.00
CLLS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5011000.00
CLLS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -4102000.00
CLLS income_statement (quarterly, 2025-09-30) — Research And Development: 24069000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 2000000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -307861000.00
CLLS income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2263000.00
CLLS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 2315000.00
CLLS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2479000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Share Issued: 100325229.00
CLLS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1602000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 100478000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 99633000.00
CLLS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLLS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
CLLS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CLLS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 18359000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Assets: 343045000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 150217000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Debt: 92776000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 100478000.00
CLLS income_statement (quarterly, 2025-09-30) — Total Expenses: 27131000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 242567000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 121852000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 93990000.00
CLLS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 8041000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 62000.00
CLLS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -7658000.00
CLLS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -7658000.00
CLLS balance_sheet (quarterly, 2025-09-30) — Working Capital: 72616000.00
CLLS income_statement (annual, 2025-12-31) — +Operating Expense: 96228000.00
CLLS income_statement (quarterly, 2025-12-31) — +Operating Expense: 24748000.00
CLLS income_statement (annual, 2025-12-31) — +Total Revenue: 72949000.00
CLLS income_statement (quarterly, 2025-12-31) — +Total Revenue: 10396000.00
CLLS balance_sheet (annual, 2025-12-31) — Accounts Payable: 17277000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17277000.00
CLLS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 14398000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 14398000.00
CLLS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -113592000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -113592000.00
CLLS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 437445000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 437445000.00
CLLS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CLLS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 5088000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 5088000.00
CLLS income_statement (annual, 2025-12-31) — Basic Average Shares: 100279276.00
CLLS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 100327726.00
CLLS income_statement (annual, 2025-12-31) — Basic EPS: -0.67
CLLS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.26
CLLS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 143251000.00
CLLS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 52243000.00
CLLS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 53751000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 53751000.00
CLLS cash_flow (annual, 2025-12-31) — Capital Expenditure: -3533000.00
CLLS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -490000.00
CLLS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 35426000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 35426000.00
CLLS balance_sheet (annual, 2025-12-31) — Capital Stock: 5903000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5903000.00
CLLS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 61533000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 61533000.00
CLLS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 208663000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 208663000.00
CLLS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
CLLS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
CLLS balance_sheet (annual, 2025-12-31) — Cash Equivalents: 15618000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 15618000.00
CLLS balance_sheet (annual, 2025-12-31) — Cash Financial: 45915000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 45915000.00
CLLS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -16761000.00
CLLS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4141000.00
CLLS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -29484000.00
CLLS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 22451000.00
CLLS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -39401000.00
CLLS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10360000.00
CLLS cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
CLLS cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
CLLS cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
CLLS cash_flow (annual, 2025-12-31) — Change In Account Payable: -3259000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2497000.00
CLLS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -28883000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 2301000.00
CLLS cash_flow (annual, 2025-12-31) — Change In Payable: -3259000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Payable: 2497000.00
CLLS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3259000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2497000.00
CLLS cash_flow (annual, 2025-12-31) — Change In Receivables: -9451000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -6170000.00
CLLS cash_flow (annual, 2025-12-31) — Change In Working Capital: -41593000.00
CLLS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1372000.00
CLLS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5020000.00
CLLS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6573000.00
CLLS cash_flow (annual, 2025-12-31) — Changes In Cash: -85646000.00
CLLS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7950000.00
CLLS balance_sheet (annual, 2025-12-31) — Common Stock: 5903000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Common Stock: 5903000.00
CLLS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 75901000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 75901000.00
CLLS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 44000.00
CLLS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 44000.00
CLLS balance_sheet (annual, 2025-12-31) — Construction In Progress: 1363000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1363000.00
CLLS income_statement (annual, 2025-12-31) — Cost Of Revenue: 9797000.00
CLLS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2999000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 10766000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 10766000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Assets: 236245000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Assets: 236245000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 7701000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 7701000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Debt: 4090000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Debt: 4090000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11791000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11791000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 96803000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 96803000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 96803000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 96803000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Liabilities: 145751000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 145751000.00
CLLS balance_sheet (annual, 2025-12-31) — Current Provisions: 1169000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Current Provisions: 1169000.00
CLLS cash_flow (annual, 2025-12-31) — Deferred Income Tax: -423000.00
CLLS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -423000.00
CLLS cash_flow (annual, 2025-12-31) — Deferred Tax: -423000.00
CLLS cash_flow (quarterly, 2025-12-31) — Deferred Tax: -423000.00
CLLS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 20062000.00
CLLS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5103000.00
CLLS income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1397000.00
CLLS income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 306000.00
CLLS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 20062000.00
CLLS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5103000.00
CLLS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1397000.00
CLLS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 306000.00
CLLS balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 22059000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 22059000.00
CLLS income_statement (annual, 2025-12-31) — Diluted Average Shares: 100279276.00
CLLS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 100327726.00
CLLS income_statement (annual, 2025-12-31) — Diluted EPS: -0.67
CLLS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.26
CLLS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -67593000.00
CLLS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -26318000.00
CLLS income_statement (annual, 2025-12-31) — EBIT: -59909000.00
CLLS income_statement (quarterly, 2025-12-31) — EBIT: -24708000.00
CLLS income_statement (annual, 2025-12-31) — EBITDA: -39847000.00
CLLS income_statement (quarterly, 2025-12-31) — EBITDA: -19605000.00
CLLS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3928000.00
CLLS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1340000.00
CLLS balance_sheet (annual, 2025-12-31) — Employee Benefits: 1329000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1329000.00
CLLS cash_flow (annual, 2025-12-31) — End Cash Position: 61533000.00
CLLS cash_flow (quarterly, 2025-12-31) — End Cash Position: 61533000.00
CLLS balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
CLLS balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
CLLS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -16761000.00
CLLS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4140000.00
CLLS balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -33316000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -33316000.00
CLLS cash_flow (annual, 2025-12-31) — Free Cash Flow: -42934000.00
CLLS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -10850000.00
CLLS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -36331000.00
CLLS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -9435000.00
CLLS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -33316000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -33316000.00
CLLS income_statement (annual, 2025-12-31) — General And Administrative Expense: 8596000.00
CLLS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1496000.00
CLLS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 535000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 535000.00
CLLS balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 14398000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 14398000.00
CLLS balance_sheet (annual, 2025-12-31) — Gross PPE: 176038000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 176038000.00
CLLS income_statement (annual, 2025-12-31) — Gross Profit: 63152000.00
CLLS income_statement (quarterly, 2025-12-31) — Gross Profit: 7397000.00
CLLS income_statement (annual, 2025-12-31) — Interest Expense: 8107000.00
CLLS income_statement (quarterly, 2025-12-31) — Interest Expense: 2034000.00
CLLS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 8107000.00
CLLS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2034000.00
CLLS income_statement (annual, 2025-12-31) — Interest Income: 9498000.00
CLLS income_statement (quarterly, 2025-12-31) — Interest Income: 2078000.00
CLLS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 9498000.00
CLLS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2078000.00
CLLS cash_flow (annual, 2025-12-31) — Interest Paid Cff: -612000.00
CLLS cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -111000.00
CLLS cash_flow (annual, 2025-12-31) — Interest Received Cfo: 8428000.00
CLLS cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 1317000.00
CLLS balance_sheet (annual, 2025-12-31) — Invested Capital: 131208000.00
CLLS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 131208000.00
CLLS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -29484000.00
CLLS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 22451000.00
CLLS balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 5088000.00